David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$696M |
| 2 |
Apple
AAPL
|
+$379M |
| 3 |
Bristol-Myers Squibb
BMY
|
+$289M |
| 4 |
Keurig Dr Pepper
KDP
|
+$275M |
| 5 |
Meta Platforms (Facebook)
META
|
+$241M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
TWX
Time Warner Inc
TWX
|
+$648M |
| 2 |
Merck
MRK
|
+$453M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$390M |
| 4 |
TWTR
Twitter, Inc.
TWTR
|
+$273M |
| 5 |
Broadcom
AVGO
|
+$265M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.15% |
| 2 | Consumer Discretionary | 12.62% |
| 3 | Healthcare | 10.65% |
| 4 | Financials | 9.26% |
| 5 | Industrials | 6.77% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ACHN
2726
DELISTED
Achillion Pharmaceuticals
ACHN
| $889K | ﹤0.01% |
314,007
-23,779
| -7% | -$81K |
|
2727
Intrepid Potash
IPI
$509M
| $886K | ﹤0.01% |
21,616
+14,541
| +206% | +$635K |
|
2728
Ally Financial
ALLY
$13B
| $883K | ﹤0.01% |
+33,622
| New | +$897K |
|
2729
PDS Biotechnology
PDSB
$12.4M
| $883K | ﹤0.01% |
42,833
+41,085
| +2,350% | +$857K |
|
2730
MongoDB
MDB
$32.6B
| $878K | ﹤0.01% |
+17,692
| New | +$794K |
|
2731
CALL
Stryker
SYK
$127B
| $878K | ﹤0.01% |
5,200
+3,600
| +225% | +$605K |
|
|
AUTO
2732
DELISTED
AutoWeb, Inc. Common Stock
AUTO
| $875K | ﹤0.01% |
193,603
-14,029
| -7% | -$52.4K |
|
2733
CALL
Royal Gold
RGLD
$22.7B
| $873K | ﹤0.01% |
+9,400
| New | +$841K |
|
2734
CALL
MetLife
MET
$60.9B
| $872K | ﹤0.01% |
+20,000
| New | +$932K |
|
2735
3M
MMM
$92.5B
| $872K | ﹤0.01% |
5,302
-59,110
| -92% | -$10.1M |
|
|
SRCL
2736
DELISTED
Stericycle Inc
SRCL
| $870K | ﹤0.01% |
13,323
-90,606
| -87% | -$5.64M |
|
|
HA
2737
CALL
DELISTED
Hawaiian Holdings, Inc.
HA
| $870K | ﹤0.01% |
24,200
+15,800
| +188% | +$609K |
|
|
CYOU
2738
PUT
DELISTED
Changyou.com Limited American Depositary Share
CYOU
| $867K | ﹤0.01% |
52,000
+17,900
| +52% | +$388K |
|
2739
Ardelyx
ARDX
$976M
| $866K | ﹤0.01% |
234,115
+190,961
| +443% | +$886K |
|
|
LSI
2740
PUT
DELISTED
Life Storage, Inc.
LSI
| $866K | ﹤0.01% |
13,350
-23,550
| -64% | -$1.42M |
|
|
PERY
2741
DELISTED
Perry Ellis International Inc
PERY
| $866K | ﹤0.01% |
31,880
-2,223
| -7% | -$59.5K |
|
2742
iShares MSCI India ETF
INDA
$6.7B
| $865K | ﹤0.01% |
+25,974
| New | +$881K |
|
2743
Assurant
AIZ
$14.1B
| $861K | ﹤0.01% |
8,317
-87,870
| -91% | -$8.26M |
|
2744
Brookfield
BN
$94B
| $861K | ﹤0.01% |
59,426
-297,625
| -83% | -$4.25M |
|
2745
Salesforce
CRM
$168B
| $860K | ﹤0.01% |
6,306
-191,455
| -97% | -$24.4M |
|
2746
Vulcan Materials
VMC
$35.5B
| $860K | ﹤0.01% |
+6,667
| New | +$822K |
|
2747
Acadia Pharmaceuticals
ACAD
$5.27B
| $859K | ﹤0.01% |
+56,267
| New | +$1M |
|
2748
CALL
Travel + Leisure Co
TNL
$4.51B
| $859K | ﹤0.01% |
19,400
-23,571
| -55% | -$1.16M |
|
2749
Rogers Corp
ROG
$2.23B
| $858K | ﹤0.01% |
7,697
-10,295
| -57% | -$1.2M |
|
|
RDS.B
2750
DELISTED
Royal Dutch Shell PLC ADS Class B
RDS.B
| $855K | ﹤0.01% |
+11,766
| New | +$847K |
|
Similar funds
David Shaw's Q2 2018 Portfolio in Review
As of Q2 2018, David Shaw held 4,066 positions worth $76.7B, up 4.4% from $73.5B the previous quarter. Its ten largest holdings account for 9.8% of the portfolio.
David Shaw's Q2 2018 filing shows 622 new, 1,512 increased, 1,263 reduced and 399 closed positions. Its largest new stake was Evergy: 4,161,679 shares worth $234M. The largest sale was Time Warner Inc, an estimated $648M.
By sector, the portfolio is most concentrated in Technology at 15% of assets, down from 16% a quarter earlier, followed by Consumer Discretionary and Healthcare.
- David Shaw's largest Q2 2018 buy was Evergy: 4,161,679 shares worth $234M.
- David Shaw added most to Amazon in Q2 2018, an estimated $696M increase.
- David Shaw's biggest Q2 2018 reduction was Merck, cutting an estimated $453M.
- David Shaw fully exited Time Warner Inc in Q2 2018, selling an estimated $648M.
- David Shaw's ten largest holdings make up 9.8% of its $76.7B portfolio in Q2 2018.
- David Shaw opened 622 new positions and closed 399 in Q2 2018.
- David Shaw's portfolio value rose 4.4% quarter-over-quarter to $76.7B.
Based on D.E. Shaw & Co's 13F filing for Q2 2018, filed 14 Aug 2018.